Risk factor
Fair trading liquidity
Profitability factor
Slightly undervalued vs peers
About
PKU HealthCare Corp.,Ltd. researches, develops, manufactures, and sells pharmaceutical products in China. It offers products in various categories, including anti-tumor, neuropsychiatric, cardiovascular, immunosuppressive, antimicrobial, antipyretic and analgesic, digestive system, regulate immunity, oncology, anti-allergic, blood sugar regulation, mental disorder, and blood volume expansion. The company was formerly known as PUK International Hospital Group Southwest Synthetic Pharmaceutical Corp., Ltd. and changed its name to PKU HealthCare Corp., Ltd. in November 2013. PKU HealthCare Corp.,Ltd. was founded in 1965 and is headquartered in Chongqing, China.
Company Valuation
From both historical and forecast perspectives, the stock is moderately underpriced compared to similar stocks. Specifically, the stock is 'expensive' on P/E, overvalued